These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25534140)

  • 21. The therapeutic potential of GPR119 agonists for type 2 diabetes.
    Ohishi T; Yoshida S
    Expert Opin Investig Drugs; 2012 Mar; 21(3):321-8. PubMed ID: 22292451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pramlintide in the treatment of type 1 and type 2 diabetes mellitus.
    Ryan GJ; Jobe LJ; Martin R
    Clin Ther; 2005 Oct; 27(10):1500-12. PubMed ID: 16330288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can targeting SIRT-1 to treat type 2 diabetes be a good strategy? A review.
    Pulla VK; Battu MB; Alvala M; Sriram D; Yogeeswari P
    Expert Opin Ther Targets; 2012 Aug; 16(8):819-32. PubMed ID: 22762724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quo vadis nateglinide? Ten-year perspective.
    Grunberger G
    Expert Opin Pharmacother; 2011 Sep; 12(13):2097-106. PubMed ID: 21801074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The therapeutic potential of GPR120: a patent review.
    Halder S; Kumar S; Sharma R
    Expert Opin Ther Pat; 2013 Dec; 23(12):1581-90. PubMed ID: 24094095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New targets in type 2 diabetes therapy].
    Hinneburg I
    Med Monatsschr Pharm; 2010 Aug; 33(8):280-4. PubMed ID: 21189647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promising new approaches.
    Reasner CA
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medicinal chemistry approaches to the inhibition of dipeptidyl peptidase-4 for the treatment of type 2 diabetes.
    Havale SH; Pal M
    Bioorg Med Chem; 2009 Mar; 17(5):1783-802. PubMed ID: 19217790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL; Wolf SL; Kabadi UM
    Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Hot and Potential Targets of Type 2 Diabetes Mellitus Treatment in Recent Decade.
    Xu Q; Wang L; Luo J; Shi D
    Curr Drug Targets; 2018; 19(1):55-69. PubMed ID: 28270085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hypoglycemic treatment of type 2 diabetes].
    Thorsby P; Kilhovd B; Sletmo R; Martinsen S; Birkeland KI
    Tidsskr Nor Laegeforen; 2000 Aug; 120(20):2434-40. PubMed ID: 11475233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Examining the safety of PPAR agonists - current trends and future prospects.
    Bortolini M; Wright MB; Bopst M; Balas B
    Expert Opin Drug Saf; 2013 Jan; 12(1):65-79. PubMed ID: 23134541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rationale for dipeptidyl peptidase 4 inhibitors: a new class of oral agents for the treatment of type 2 diabetes mellitus.
    Campbell RK
    Ann Pharmacother; 2007 Jan; 41(1):51-60. PubMed ID: 17190843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medically minimising the impact of hypoglycaemia in type 2 diabetes: a review.
    Noh RM; Graveling AJ; Frier BM
    Expert Opin Pharmacother; 2011 Oct; 12(14):2161-75. PubMed ID: 21668402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging sodium/glucose co-transporter 2 inhibitors for type 2 diabetes.
    Boyle LD; Wilding JP
    Expert Opin Emerg Drugs; 2013 Sep; 18(3):375-91. PubMed ID: 23968378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of pharmacologic agents for type 2 diabetes mellitus on body weight.
    Pi-Sunyer FX
    Postgrad Med; 2008 Jul; 120(2):5-17. PubMed ID: 18654064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Achieving glycemic control in type 2 diabetes: a practical guide for clinicians on oral hypoglycemics.
    Willett LL; Albright ES
    South Med J; 2004 Nov; 97(11):1088-92. PubMed ID: 15586599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in the treatment of type 2 diabetes mellitus.
    Israili ZH
    Am J Ther; 2011; 18(2):117-52. PubMed ID: 19834322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GPR119 agonists for the potential treatment of type 2 diabetes and related metabolic disorders.
    Shah U; Kowalski TJ
    Vitam Horm; 2010; 84():415-48. PubMed ID: 21094910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.